SleepCogni raises £1.4m Series A funding from Chasnay Capital Partners and others to scale into the US market
The round was backed by Chasnay Capital Partners alongside existing investors, retail investors, and Innovate UK.
SleepCogni is a medical technology company based in Sheffield that develops digital solutions for insomnia care. The firm combines clinical insights with advanced monitoring to improve patient outcomes.
SleepCogni has secured £1.4m in a Series A round combining debt and equity, surpassing its initial target and bringing total funding to £3.2m. The investment comes from participants including Chasnay Capital Partners, existing backers, retail investors, and Innovate UK. The company plans to use the capital to prepare its medical device for volume manufacturing, develop online platforms for patients and clinicians, and drive initial sales as it expands into the US market. This financing follows positive clinical trial results and precedes planned US market entry.
From the founder
"My north star is who I work with, and the level of enthusiasm, passion and desire to do great things at SleepCogni is outstanding. SleepCogni is a great example of hardware and software working together to have a truly life changing impact on patients."
Colin Greene
Executive at SleepCogni
Use of funds
- 01Continue product development
- 02Invest in sales and marketing
- 03Expand into international markets
Investors
Categories
About the company
SleepCogni
SleepCogni builds digital technology to transform insomnia care and sleep health.